Genetics of infectious disease resistance

Current Opinion in Genetics and Development

Volumn 6, Issue 3, 1996, Pages 348-353

  Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE PREDISPOSITION; FAMILY; GENE ISOLATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SCREENING; HUMAN; INFECTION; INFECTION RESISTANCE; LEISHMANIASIS; MALARIA; METHODOLOGY; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029895717     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)80013-X     Document Type: Article

References (51)

1. Mcleod R, Buschman E, Arbuckle LD, Skamene E: Immunogenetics in the analysis of resistance to intracellular pathogens. Curr Opin Immunol 1995, 7:539-552.
2. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N et al.: Natural selection of heml- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995, 376:246-249. Two large case-control studies of African children with severe malaria provide an estimate of the degree of protection afforded by this enzyme deficiency, -50% reduction in risk. Both male hemizygotes and female heterozygotes were shown to protected.
3. Tournamille C, Colin Y, Cartron JP, Kim CLV: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995, 10: 224-228.
4. Hill AVS, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM: Common west African HLA antigens are associated with protection from severe malaria. Nature 1991, 352:595-600.
5. Hill AVS, Yates SN, Allsopp CE, Gupta S, Gilbert SC, Lalvani A, Aidoo M, Davenport M, Plebanski M: Human leukocyte antigens and natural selection by malaria. Philos Trans R Soc Lond B Biol Sci 1994, 346:379-385.
6. McGuire W, Hill AVS, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994, 371:508-510. Association of a cytokine gene variant with an infectious disease; in a case-control study of Gambian children, homozygotes for a promoter variant at position -308 of the TNF gene were at a substantially increased risk of cerebral malaria. This association was found to be independent of associations previously identified [3] with HLA class I and II genes.
7. Cabrera M, Shaw M-A, Sharpies C, Williams H, Castes M, Convit C, Blackwell JM: Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995, 182:1259-1264.
8. Meyer CG, Gallin M, Erttmann KD, Brattig N, Schnittger L, Gelhaus A, Tannich E, Begovich AB, Erlich HA, Horstmann RD: HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci USA 1994, 91:7515-7519.
9. Yazdanbaksh M, Sartono E, Kruize YCM, Kurniawan A, Partono F, Maizels RM, Schreuder GMT, Schipper R, De Vries RRP: HLA and elephantiasis in lymphatic filariasis. Hum Immunol 1995, 44:58-61.
10. Stead WW, Senner JW, Reddick WT, Lofgren JP: Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990, 322:422-427.
11. Rani R, Fernandez Vina MA, Zaheer SA, Beena KR, Stastny P: Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens 1993, 42:133-137.
12. Todd JR, West BC, McDonald JC: Human leukocyte antigen and leprosy: study in northern Louisiana and review. Rev Infect Dis 1990, 12:63-74.
13. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, Kwang TY, Hsu ST, Lin SY, Hsu LC: Hepatitis B virus markers in Chinese twins. Anticancer Res 1989, 9:737-742.
14. Almarri A, Batchelor JR: HLA and hepatitis B infection. Lancet 1994, 344:1194-1195. Quatari patients with chronic carriage of hepatitis B virus were found to have altered HLA-DR allele frequencies compared to controls.
15. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV: Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995, 332:1065-1069. Asymptomatic carriers of hepatitis B virus in the Gambia were less likely to have the HLA-DRB1*1302 allele, suggesting that an immune response restricted by this HLA type may facilitate viral clearance. Recent analysis by Davenport et al. [51] of the sequence of peplides bound by this molecule should facilitate molecular immunological analysis of this HLA-disease association.
16. Klein MR, Keet IP, D'Amoro J, Bende RJ, Hekman A, Mesman B, Koot M, De Waal LP, Coutinho RA, Miedema F: Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994, 169: 1244-1249.
17. Kroner BL, Goedert JJ, Blattner WA, Wilson SE, Carrington MN, Mann DL: Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. AIDS 1995, 9:275-280. An affected-sibling pair approach to assessing the influence of the major histocompatibility complex on the rate of disease progression in HIV infection.
18. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallmore A, Corrah T et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995, 1:59-64.
19. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994, 371: 130-136. The first study to report a complete genome scan for the mapping of susceptibility genes in a multifactorial disease of humans. A similar approach to mapping and identifying genes for human infectious diseases should be feasible.
20. Copeman JB, Cuccia F, Hearnr CM, Cornall RJ, Reed PW, Rønningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, et al.: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995, 9:80-85. Use of the transmission disequilibrium test in parent/offspring pairs to map more finely a diabetes susceptibility gene. Such an approach may be valuable for many common acute infectious diseases of children.
21. Todd JA: Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 1995, 92:8560-8565.
22. Risch N, Ghosh S, Todd JA: Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993, 53:702-714.
23. Reeves RH, BF OH, Pavan WJ, Gearhart JD, Haller O: Genetic mapping of the Mx influenza virus resistance gene within the region of mouse chromosome 16 that is homologous to human chromosome 21. J Virol 1988, 62:4372-4375.
24. Vidal SM, Malo D, Vogan K, Skamene E, Gros P: Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993, 73:469-485.
25. De Vries RR, Fat RF, Nijenhuis LE, Van Rood JJ: HLA-linked genetic control of host response to Mycobacterium leprae. Lancet 1976, 2:1328-1330.
26. Van Eden W, De Vries RR, Mehra NK, Vaidya MC, J DA, Van Rood JJ: HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J Infect Dis 1980, 141:693-701.
27. Hill AVS: Malaria resistance genes: a natural selection. Trans R Soc Trop Med Hyg 1992, 86:225,232-233.
28. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich Kautzky E, Schou C, Krishnaswamy G, Beaty TH: Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994, 264:1152-1156. Mapping of a gene for serum IgE levels to chromosome 5 in the region of a cluster of "TH2-type" cytokine genes, including IL-4 and IL-5. The polymorphic gene in this region should be a major candidate gene for several infectious disease, particularly those caused by helminth infections.
29. Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, Turner MW: High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992, 1:709-715.
30. Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, Svejgaard A: A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994, 40:37-44.
31. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A: Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995, 155:3013-3020.
32. Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, Summerfield JA: Molecular basis of opsonic defect in immunodeficient children. Lancet 1991, 337:1569-1570.
33. Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, Turner MW: Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995, 345:886-889. Establishes mannose-binding protein as a candidate gene for infectious diseases of adults as well as children.
34. Garred P, Madsen HO, Hofmann B, Svejgaard A: Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995, 346:941-943. In a large series of patients with immunodeficiency an increased frequency of individuals homozygous for mannose-binding protein deficiency alleles was found. This study suggests that homozygotes rather than heterozygotes for MBP-deficiency alleles are those at risk of infection.
35. Nielsen SL, Andersen PL, Koch C, Jensenius JC, Thiel S: The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol 1995, 100:219-222.
36. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A: Dual role of mannan-binding protein in infections: another case of heterosis? Euro J Immunogen 1994, 21:125-131.
37. Garred P, Brygge K, Sorensen CH, Madsen HO, Thiel S, Svejgaard A: Mannan-binding protein-levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clin Exp Immunol 1993, 94:99-104.
38. Blackwell CC, Jonsdottir K, Hanson M, Todd WT, Chaudhuri AK, Mathew B, Brettle RP, Weir DM: Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 1986, 2:284-285.
39. Thom SM, Blackwell CC, MacCallum CJ, Weir DM, Brettle RP, Kinane DF, Wray O: Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol 1989, 1:401-405.
40. Kinane DF, Blackwell CC, Winstanley FP, Weir DM: Blood group, secretor status, and susceptibility to infection by Neisseria gonorrhoeae. Br J Vener Dis 1983, 59:44-46.
41. Raza MW, Blackwell CC, Molyneaux P, James VS, Ogilvie MM, Inglis JM, Weir DM: Association between secretor status and respiratory viral illness. BMJ 1991, 303:815-818.
42. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB: Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995, 270:4640-4649. The molecular basis of the non-secretor phenotype defined. All alleles studied had the same stop-codon mutalion. This allows the relevance of this variant to infectious disease susceptibility to be readily assessed by DNA anaysis.
43. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P: The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995, 182:655-666. Confirmation that the susceptibilty locus Lsb/Ity/Bcg in mice encodes the Nramp1 gene.
44. Shaw MA, Atkinson S, Dockrell H, Hussain R, Lins Lainson Z, Shaw J, Ramos F, Silveira F, Mehdi SQ, Kaukab F, Blackwell JM: An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. Ann Hum Genet 1993, 57:251-271.
45. Levee G, Liu J, Gicquel B, Chanteau S, Schurr E: Genetic control of susceptibility to leprosy in French Polynesia; no evidence for linkage with markers on telomeric human chromosome 2. Int J Lepr Other Mycobact Dis 1994, 62:499-511. Further evidence, supporting the findings in [44], that NRAMP1 in humans may not be a susceptibility gene for leprosy.
46. Blackwell JM, Barton CH, White JK, Searle S, Baker A-M, Williams H, Shaw M-A: Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995, 1:194-205. Identification of a microsatellite in the NRAMP1 promoter of value for infectious disease linkage and association studies.
47. Liu J, Fujiwara TM, Buu NT, Sanchez FO, Cellier M, Paradis AJ, Frappier D, Skamene E, Gros P, Morgan K, Schurr E: Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995, 56:845-853. Identification of several polymorphisms in the NRAMP1 gene of value for infectious disease association and linkage studies.
48. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, Haller O: Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol 1995, 69:4506-4510.
49. Bredius RG, Derkx BH, Fijen CA, De Wit TP, De Haas M, Weening RS, Van de Winkel JG, Out TA: Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994, 170:848-853.
50. Sanders LA, Van de Winkel JG, Rijkers GT, Voorhorst Ogink MM, De Haas M, Capel PJ, Zegers BJ: Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994, 170:854-861.
51. Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, Bell JI, Hill AVS: Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc Natl Acad Sci USA 1995, 92: 6567-6571.